Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
How Early Is Early Multiple Sclerosis?
Stavropoulou De Lorenzo S, Bakirtzis C, Konstantinidou N, Kesidou E, Parissis D, Evangelopoulos ME, Elsayed D, Hamdy E, Said S, Grigoriadis N. Stavropoulou De Lorenzo S, et al. Among authors: evangelopoulos me. J Clin Med. 2023 Dec 29;13(1):214. doi: 10.3390/jcm13010214. J Clin Med. 2023. PMID: 38202221 Free PMC article. Review.
CNS Ageing in Health and Neurodegenerative Disorders.
Kesidou E, Theotokis P, Damianidou O, Boziki M, Konstantinidou N, Taloumtzis C, Sintila SA, Grigoriadis P, Evangelopoulos ME, Bakirtzis C, Simeonidou C. Kesidou E, et al. Among authors: evangelopoulos me. J Clin Med. 2023 Mar 14;12(6):2255. doi: 10.3390/jcm12062255. J Clin Med. 2023. PMID: 36983254 Free PMC article. Review.
Immune reconstitution inflammatory syndrome mimicking progressive multifocal leucoencephalopathy in a multiple sclerosis patient treated with natalizumab: a case report and review of the literature.
Evangelopoulos ME, Koutoulidis V, Kilidireas K, Evangelopoulos DS, Nakas G, Andreadou E, Moulopoulos LA. Evangelopoulos ME, et al. Among authors: evangelopoulos ds. J Clin Med Res. 2015 Jan;7(1):65-8. doi: 10.14740/jocmr1888w. Epub 2014 Oct 16. J Clin Med Res. 2015. PMID: 25368707 Free PMC article.
Co-occurrence between hereditary angioedema and multiple sclerosis: Therapeutic management of both diseases with fingolimod.
Vakrakou AG, Tzanetakos D, Giagkou E, Evangelopoulos ME, Anagnostouli M, Andreadou E, Koutsis G, Dimitrakopoulos A, Gialafos E, Tzartos JS, Kompoti E, Fragoulis GE, Stefanis L, Kilidireas C. Vakrakou AG, et al. Among authors: evangelopoulos me. Clin Neurol Neurosurg. 2022 May;216:107222. doi: 10.1016/j.clineuro.2022.107222. Epub 2022 Mar 28. Clin Neurol Neurosurg. 2022. PMID: 35378480
Alemtuzumab-induced alopecia universalis and transient accommodation spasm in a patient with multiple sclerosis.
Tzanetakos D, Breza M, Tzartos JS, Bontzos G, Vakrakou AG, Dermentzoglou A, Gkizis I, Smoustopoulos G, Evangelopoulos ME, Stefanis L, Kilidireas C. Tzanetakos D, et al. Among authors: evangelopoulos me. Ther Adv Neurol Disord. 2022 Oct 8;15:17562864221127476. doi: 10.1177/17562864221127476. eCollection 2022. Ther Adv Neurol Disord. 2022. PMID: 36225970 Free PMC article.
Natalizumab therapy in patients with pediatric-onset multiple sclerosis in Greece: clinical and immunological insights of time-long administration and future directions-a single-center retrospective observational study.
Gontika M, Skarlis C, Markoglou N, Tzanetakos D, Vakrakou A, Toulas P, Koutsis G, Evangelopoulos ME, Pons R, Dardiotis E, Chrousos G, Dalakas M, Stefanis L, Anagnostouli M. Gontika M, et al. Among authors: evangelopoulos me. Naunyn Schmiedebergs Arch Pharmacol. 2022 Aug;395(8):933-943. doi: 10.1007/s00210-022-02238-y. Epub 2022 Apr 26. Naunyn Schmiedebergs Arch Pharmacol. 2022. PMID: 35471586
IgG4-related autoimmune manifestations in Alemtuzumab-treated multiple sclerosis patients.
Vakrakou AG, Tzanetakos D, Evangelopoulos ME, Fragoulis GE, Kazakou P, Lekka E, Kafasi N, Tzartos JS, Andreadou E, Koutsis G, Gialafos E, Dimitrakopoulos A, Zampeli E, Rontogianni D, Theocharis S, Zapanti E, Stathopoulos PA, Anagnostouli M, Stefanis L, Kilidireas C. Vakrakou AG, et al. Among authors: evangelopoulos me. J Neuroimmunol. 2021 Dec 15;361:577759. doi: 10.1016/j.jneuroim.2021.577759. Epub 2021 Oct 29. J Neuroimmunol. 2021. PMID: 34742035
Hypogammaglobulinemia: A contributing factor to multiple sclerosis fatigue?
Diem L, Evangelopoulos ME, Karathanassis D, Natsis V, Kamber N, Hammer H, Friedli C, Chan A, Helbling A, Penner IK, Salmen A, Walther S, Stegmayer K, Hoepner R. Diem L, et al. Among authors: evangelopoulos me. Mult Scler Relat Disord. 2022 Dec;68:104148. doi: 10.1016/j.msard.2022.104148. Epub 2022 Aug 30. Mult Scler Relat Disord. 2022. PMID: 36063730 Free article.
Pathological cerebrospinal fluid protein concentration and albumin quotient at relapse predicts short-term disability progression in multiple sclerosis: a retrospective single center observational study.
Diem L, Bürge M, Leichtle A, Hakim A, Chan A, Salmen A, Evangelopoulos ME, Hoepner R. Diem L, et al. Among authors: evangelopoulos me. Ther Adv Neurol Disord. 2020 Dec 29;13:1756286420975909. doi: 10.1177/1756286420975909. eCollection 2020. Ther Adv Neurol Disord. 2020. PMID: 33447262 Free PMC article.
90 results